ArticlePloS one2025
Gender differences in the association between pan-immune-inflammation value and probable depression: A cross-sectional study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explored the non-linear relationship between pan-immune inflammation value (PIV) and probable depression using NHANES data (2005-2018, n = 27,049). Restricted cubic spline analysis identified an optimal PIV cutoff (5.74). Weighted logistic regression revealed that individuals with PIV > 5.74 had 14% higher risk of probable depression (OR=1.14, 95% CI:1.02-1.28). Gender-stratified analyses showed significant PIV and probable depression associations in females (OR=1.20, 95% CI:1.03-1.40) but not in males. In males, higher PIV interacted with age, education, and alcohol consumption to influence probable depression risk (interaction P < 0.05), whereas no such interactions occurred in females. The findings suggest PIV may serve as a sex-specific biomarker for probable depression risk, with more stable associations in females. Further research is needed to elucidate the mechanisms underlying these gender differences and validate these findings before any clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.